BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 33628373)

  • 1. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
    Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
    Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis.
    Wakamatsu T; Yamamoto S; Yoshida S; Narita I
    Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota and Cardiovascular Uremic Toxicities.
    Velasquez MT; Centron P; Barrows I; Dwivedi R; Raj DS
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29997362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
    Lekawanvijit S
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease].
    Mikhailova NA
    Ter Arkh; 2021 Jun; 93(6):729-735. PubMed ID: 36286841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
    Wu CL; Tarng DC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD.
    Pieniazek A; Bernasinska-Slomczewska J; Gwozdzinski L
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
    Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review.
    Holmar J; de la Puente-Secades S; Floege J; Noels H; Jankowski J; Orth-Alampour S
    Cells; 2020 Nov; 9(11):. PubMed ID: 33172085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.
    Florens N; Calzada C; Lyasko E; Juillard L; Soulage CO
    Toxins (Basel); 2016 Dec; 8(12):. PubMed ID: 27999257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences.
    Spence JD; Urquhart BL
    Curr Neurol Neurosci Rep; 2022 Nov; 22(11):757-766. PubMed ID: 36181576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Uremic Toxins in Early Vascular Ageing and Calcification.
    Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic kidney disease-a cardiovascular high-risk constellation].
    Speer T; Schunk SJ; Fliser D
    Internist (Berl); 2020 Apr; 61(4):340-348. PubMed ID: 31578597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic Toxins and Vascular Dysfunction.
    Six I; Flissi N; Lenglet G; Louvet L; Kamel S; Gallet M; Massy ZA; Liabeuf S
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32570781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease.
    Moradi H; Sica DA; Kalantar-Zadeh K
    Am J Nephrol; 2013; 38(2):136-48. PubMed ID: 23941724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic renal disease, inflammation and atherosclerosis: new concepts about an old problem].
    Dummer CD; Thomé FS; Veronese FV
    Rev Assoc Med Bras (1992); 2007; 53(5):446-50. PubMed ID: 17952355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.